Exchange Plan Formularies Will Have P&T Review Plus Drug Count Requirement
This article was originally published in The Pink Sheet Daily
Executive Summary
Under a final HHS rule on parameters for Affordable Care Act exchange plans, insurers will continue to meet existing standards for the number of drugs covered in each class but also must have pharmacy and therapeutics committees review the adequacy of drug coverage starting in 2017.